The Impact of Vitamin D Supplementation on Improving Blood Pressure: Evidence Obtained From an Umbrella Meta-analysis.


Journal

Clinical therapeutics
ISSN: 1879-114X
Titre abrégé: Clin Ther
Pays: United States
ID NLM: 7706726

Informations de publication

Date de publication:
10 2023
Historique:
received: 21 04 2023
revised: 07 07 2023
accepted: 25 07 2023
medline: 13 11 2023
pubmed: 24 8 2023
entrez: 23 8 2023
Statut: ppublish

Résumé

The results of meta-analyses regarding the effect of vitamin D on blood pressure are conflicting. The present umbrella meta-analysis was conducted to provide definite and conclusive results. Systematically, Scopus, EMBASE, PubMed, and Web of Science databases and Google Scholar were searched for relevant literature published up to July 2022. All meta-analyses of clinical trials addressing the effect of vitamin D on blood pressure were included. Random effects analysis was performed to obtain the overall effect size based on the standardized mean differences (SMDs) and weighted mean differences (WMDs) separately. The quality of included meta-analyses was assessed by using the Measurement Tool for Assessing Multiple Systematic Reviews 2 questionnaire. Overall, 21 meta-analyses were enrolled in the umbrella review. The results indicated that systolic blood pressure was significantly reduced after the intervention based on WMD effect size analysis (ES Based on obtained evidence, vitamin D could be considered an efficient adjuvant for improving blood pressure.

Identifiants

pubmed: 37612170
pii: S0149-2918(23)00294-1
doi: 10.1016/j.clinthera.2023.07.020
pii:
doi:

Substances chimiques

Vitamin D 1406-16-2
Vitamins 0

Types de publication

Meta-Analysis Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e208-e216

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None declared.

Auteurs

Rui Meng (R)

Medical School, Xi'an Peihua College, Xi'an, Shaanxi, China.

Nima Radkhah (N)

Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Faezeh Ghalichi (F)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Fatemeh Hamedi-Kalajahi (F)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Vali Musazadeh (V)

Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Saleh A K Saleh (SAK)

Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia; Oncology Diagnostic Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

Heba M Adly (HM)

Department of Community Medicine and Pilgrims Healthcare, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.

Mohamed Ismail Albadawi (MI)

College of Medicine, Almaarefa University, Riyadh, Saudi Arabia.

Parsa Jamilian (P)

Keele Medical School, Keele University, Staffordshire, United Kingdom.

Meysam Zarezadeh (M)

Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.

Alireza Ostadrahimi (A)

Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Jie Li (J)

Medical School, Xi'an Peihua College, Xi'an, Shaanxi, China. Electronic address: lj871023aiyajun@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH